Caterbas, Alberto S.
HRN: 20-80-04 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/29/2023
CLINDAMYCIN 300MG (CAP)
06/29/2023
07/06/2023
ORAL
300 Mg
Q8h
S/P BKA, Right
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes